WAVE Life Sciences Ltd
NASDAQ:WVE

Watchlist Manager
WAVE Life Sciences Ltd Logo
WAVE Life Sciences Ltd
NASDAQ:WVE
Watchlist
Price: 8.08 USD -6.26%
Market Cap: 1.2B USD

Intrinsic Value

WVE's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one WVE stock under the Base Case scenario is 4.72 USD. Compared to the current market price of 8.08 USD, WAVE Life Sciences Ltd is Overvalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

WVE Intrinsic Value
4.72 USD
Overvaluation 42%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
WAVE Life Sciences Ltd

WVE
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for WVE cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

WAVE Life Sciences Ltd
NASDAQ:WVE
SG
Pharmaceuticals
Market Cap
1.2B USD
IPO
Nov 11, 2015
SG
Pharmaceuticals
Market Cap
1.2B USD
IPO
Nov 11, 2015
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about WVE?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about WAVE Life Sciences Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
WAVE Life Sciences Ltd

Current Assets 320.4m
Cash & Short-Term Investments 302.1m
Receivables 1.4m
Other Current Assets 16.9m
Non-Current Assets 31.8m
PP&E 28m
Other Non-Current Assets 3.8m
Efficiency

Free Cash Flow Analysis
WAVE Life Sciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
WAVE Life Sciences Ltd

Revenue
108.3m USD
Operating Expenses
-218.7m USD
Operating Income
-110.4m USD
Other Expenses
13.4m USD
Net Income
-97m USD
Fundamental Scores

WVE Profitability Score
Profitability Due Diligence

WAVE Life Sciences Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROE is Increasing
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
23/100
Profitability
Score

WAVE Life Sciences Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

WVE Solvency Score
Solvency Due Diligence

WAVE Life Sciences Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Average Altman Z-Score
66/100
Solvency
Score

WAVE Life Sciences Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

WVE Price Targets Summary
WAVE Life Sciences Ltd

Wall Street analysts forecast WVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WVE is 23.56 USD with a low forecast of 14.14 USD and a high forecast of 37.8 USD.

Lowest
Price Target
14.14 USD
75% Upside
Average
Price Target
23.56 USD
192% Upside
Highest
Price Target
37.8 USD
368% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

WAVE Life Sciences Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for WVE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

WVE Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one WVE stock?

The intrinsic value of one WVE stock under the Base Case scenario is 4.72 USD.

Is WVE stock undervalued or overvalued?

Compared to the current market price of 8.08 USD, WAVE Life Sciences Ltd is Overvalued by 42%.

Back to Top